On the basis of regional analysis, the estrogen replacement therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
North America industry is estimated to account for largest revenue share by 2036, driven by rising number of older women undergoing the menopause, which is increasing the demand for estrogen therapy in order to provide comfort and make daily life easier. The market in Europe is projected to hold a significant share in the market as well owing to advancements in technology in the healthcare industry which is resulting in development of new and improved estrogen replacement therapies with lesser side effects.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?